Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century: A Systematic Review of 111 Cases (2000-2013).
de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E, GAMES Study Group.
Medicine (Baltimore). 2015; 94. FI: 5.723 (Q1).
Endocarditis due to Streptococcus tigurinus: presentation of a case and a review of the literature.
Michelena A, Bonavila C, Zubeltzu B, Goenaga MA.
Enferm. Infec. Microbiol. Clin. 2015; 33: 575-576. FI: 2.172 (Q3).
Características de los pacientes con infección por el virus de la inmunodeficiencia humana que no reciben tratamiento antirretroviral en España: estudio PICNIT.
Domingo P, Viciana P, Castaño M, Ferrer E.
Med. Clin. 2015; 144: 43-44. FI: 1.417 (Q2).
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
Santos JR, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B, Integrase Resistance Study Group in Spain (INI-VAIN Study Group), Integrase Resistance Study Group in Spain INI-VAIN Study Group.
J Antimicrob Chemother. 2015; 70: 3087-3095. FI: 5.313 (Q1).
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).
Monge S, Díez M, Alvarez M, Guillot V, Iribarren JA, Palacios R, Delgado R, Jaén A, Blanco JR, Domingo P, Portilla J, Pérez EMJ, Garcia F, Cohorte de la Red de Investigación en Sida (CoRIS).
Clin. Microbiol. Infect. 2015; 21: 105.e1-5. FI: 5.768 (Q1).
Shorter telomere length predicts poorer immunological recovery in virologically suppressed HIV-1-infected patients treated with combined antiretroviral therapy.
Blanco JR, Jarrin I, Martinez A, Siles E, Larrayoz IM, Cañuelo A, Gutierrez F, Gonzalez-Garcia J, Vidal F, Moreno S, CoRIS-Biobanco.
J Acquir Immune Defic Syndr. 2015; 68: 21-29. FI: 4.556 (Q1).
Primary resistance to integrase strand-transfer inhibitors in Europe.
Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Staneková D, Stanojevic M, Van Laethem K, Zidovec Lepej S, Clotet B, Boucher CA, Paredes R, Wensing AM, SPREAD programme.
J Antimicrob Chemother. 2015; 70: 2885-2888. FI: 5.313 (Q1).
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
Cuervo G, Camoez M, Shaw E, Dominguez MA, Gasch O, Padilla B, Pintado V, Almirante B, Molina J, Lopez-Medrano F, Ruiz de Gopegui E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MA, Benito N, Rodriguez-Bano J, Espejo E, Pujol M, REIPI GEIH Study Grp.
BMC Infect. Dis. 2015; 15. FI: 2.613 (Q2).
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.
Efsen AM, Schultze A, Post FA, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Skrahin A, Miro JM, Caylà JA, Girardi E, Bruyand M, Obel N, Podlekareva DN, Lundgren JD, Mocroft A, Kirk OTB, HIV study group in EuroCoord.
PLoS One. 2015; 10. FI: 3.057 (Q1).
Low Risk of Liver Decompensation Among Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients With Mild Fibrosis in the Short Term.
Macias J, Mancebo M, Marquez M, Merino D, Tellez F, Rivero A, Von Wichmann, MA, Lopez-Cortes, LF, Merchante N, Santos J, Raffo M, Perez-Perez M, Camacho A, Iribarren JA, Pineda JA.
Hepatology. 2015; 61: 1503-1511. FI: 11.055 (Q1).
Spanish Collaboration on Endocarditis Group-Grupo de Apoyo al Manejo de la Endoc, Spanish Network for Research in Infectious Diseases (REIPI), Spanish Collaboration on Endocarditis Group-Grupo de Apoyo al Manejo de la Endoc. Left-sided infective endocarditis in patients with liver cirrhosis.
Ruiz-Morales J, Ivanova-Georgieva R, Fernández-Hidalgo N, García-Cabrera E, Miró JM, Muñoz P, Almirante B, Plata-Ciézar A, González-Ramallo V, Gálvez-Acebal J, Fariñas MC, Bravo-Ferrer JM, Goenaga-Sánchez MA, Hidalgo-Tenorio C, Goikoetxea-Agirre J, de Alarcón-González A.
J. Infect. 2015; 71: 627-641. FI: 4.441(Q1).
Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.
Pacheco YM, Jarrin I, Rosado I, Campins AA, Berenguer J, Iribarren JA, Rivero M, Munoz-Medina L, Bernal-Morell E, Gutierrez F, Leal M, CoRIS.
Antiviral Res. 2015; 117: 69-74. FI: 3.938 (Q1).
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
Berenguer J, Polo R, Lopez J, Lozano F, Aguirrebengoa K, Arribas JR, Blanco JR, Boix V, Casado JL, Clotet B, Crespo M, Domingo P, Estrada V, Garcia F, Gatell JM, Gonzalez-Garcia J, Gutierrez F, Iribarren JA, Knobel H, Llibre JM, Locutura J, Lopez JC, Miro JM, Moreno S, Podzamczer D, Portilla J, Pulido F, Ribera E, Riera M, Rubio R, Santos J, Sanz-Moreno J, Sanz J, Tellez MJ, Tuset M, Rivero A, GESIDA, Natl AIDS Plan.
Enferm. Infec. Microbiol. Clin. 2015; 33: 544-556. FI: 2.172 (Q3).
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
Polo R, Galindo MJ, Duenas C, Gomez C, Estrada V, Villar NGP, Locutura J, Marino A, Pascua J, Palacios R, Von Wichmman MA, Alvarez J, Asensi V, Lopez J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutierrez F, Sanz J, Martinez E, Panel Experts Metab Disorders, Natl Aids Plan SPNS, Aids Study Grp GeSIDA.
Enferm. Infec. Microbiol. Clin. 2015; 33: 41-47. FI: 2.172 (Q3).